Sljedeći

Auto Play

Dr. Pautier on Doxorubicin Plus Trabectedin in Soft Tissue Sarcoma

2 Pogledi • 07/18/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Patricia Pautier, MD, discusses the toxicity profile of doxorubicin with trabectedin in the phase 2 LMS-02 trial in patients with metastatic/advanced uterine and soft tissue leiomyosarcoma.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play